Production of human chorionic gonadotropin by sarcomas is an uncommon phenomenon that has rarely been documented. A case of a 26-year-old woman with osteosarcoma of the left fibula and high levels of serum β-human chorionic gonadotropin (β-HCG) is described. Immunoperoxidase staining showed numerous tumor cells reacting with the β-HCG antibody. Immunohistochemical studies performed on ten additional osteosarcomas demonstrated another case in which some tumor cells presented immunoreactivity for β-HCG. These results indicate that β-HCG may be used as a marker of persistent or recurrent disease in those uncommon cases of osteosarcoma in which serum levels of β-HCG are elevated at the onset of treatment.
|Original language||English (US)|
|Number of pages||4|
|Journal||Archives of Pathology and Laboratory Medicine|
|State||Published - Jan 1 1989|
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Medical Laboratory Technology